0
0
March 19, 2026
NEW DELHI — In a decisive move to bridge the gap between ancient healing traditions and modern pharmaceutical rigor, the Ministry of Ayush has unveiled a comprehensive regulatory framework aimed at standardizing Ayurveda, Siddha, Unani, and Homoeopathy (Ayush) products. Spurred by an increasing global demand for natural medicine, the Indian government has formalized strict quality controls, mandatory laboratory testing, and international certification schemes to ensure that these traditional therapies meet the same safety and efficacy benchmarks as conventional pharmaceuticals.
The shift marks a pivotal moment for the millions of consumers worldwide who turn to traditional medicine for chronic condition management and wellness. By enforcing the Drugs and Cosmetics Act of 1940 and the updated 1945 Rules, the government is signaling that “natural” must also mean “verified.“
The Backbone of Quality: The PCIM&H
At the center of this quality revolution is the Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H). Acting as the apex regulatory body, the PCIM&H is responsible for creating the “official compendia”—the rulebooks that define the identity, purity, and strength of every legal Ayush drug.
“Standardization is the bedrock of trust,” says Dr. Anita Verma, a public health researcher specializing in integrative medicine (not involved in the current legislative updates). “For years, the challenge with traditional medicine was variability. Two bottles of the same herbal supplement could have vastly different concentrations of active compounds. These new mandates aim to eliminate that guesswork.“
The PCIM&H doesn’t just write the rules; it functions as the Central Drugs Laboratory, testing samples and providing specialized training to state drug analysts to ensure that laboratory techniques remain cutting-edge.
A Multi-Layered Safety Net
The regulatory architecture is designed to monitor a product from the soil to the pharmacy shelf. Key components include:
-
Mandatory Licensing: Manufacturers must now provide documented proof of safety and effectiveness before a license is granted.
-
Good Manufacturing Practices (GMP): Adherence to Schedule T (for Ayurveda, Siddha, and Unani) and Schedule M-I (for Homoeopathy) is no longer optional. These rules dictate everything from factory hygiene to the calibration of equipment.
-
Rigorous Testing Infrastructure: Currently, 108 private laboratories and 34 State/UT laboratories are licensed to perform legal analysis on Ayush samples.
-
Market Surveillance: Drug inspectors are authorized to pull samples from retail shops. If a product is found to be “Not of Standard Quality” (NSQ), the law mandates immediate market withdrawal and potential legal action against the manufacturer.
The Global Ambition: The “Ayush Quality Mark”
Perhaps the most significant development for health-conscious consumers is the launch of the Ayush Quality Mark for Global Standards, introduced during the WHO Global Summit in late 2025. This scheme, along with the Quality Council of India’s (QCI) “Premium Mark,” allows manufacturers to undergo third-party evaluations to prove their products meet international safety limits for heavy metals, pesticides, and microbial contamination.
Furthermore, a dedicated Ayush vertical within the Central Drugs Standard Control Organization (CDSCO)—India’s equivalent to the FDA—now issues WHO Certificates of Pharmaceutical Products (WHO-CoPP). This certification is essential for the export of Ayush medicines, ensuring they are recognized as legitimate therapeutic goods in the international market.
Statistical Context and Research Growth
The scale of this oversight is supported by a massive research infrastructure. The government has established five apex councils, such as the Central Council for Research in Ayurvedic Sciences (CCRAS) and the Central Council for Research in Homoeopathy (CCRH).
These councils coordinate “Ayurveda Biology Integrated Health Research,” a scheme that provides financial assistance for clinical trials. By treating traditional ingredients with the same scientific scrutiny as synthetic molecules, researchers hope to provide the “statistical proof” that modern clinicians often find lacking.
Navigating Limitations and Counterarguments
While the progress is significant, some medical experts urge a balanced perspective. “Standardization is a massive leap forward, but it is not a cure-all,” notes Dr. Sanjay Gupta, a clinical pharmacologist. “Standardizing a product’s purity ensures it isn’t contaminated with lead or arsenic, which is vital. However, it doesn’t automatically mean the product will work for every individual or every condition. We must continue to demand high-quality, peer-reviewed clinical data.”
Skeptics also point out that the sheer number of small-scale traditional pharmacies makes enforcement a logistical challenge. Ensuring that every local manufacturer complies with the stringent 1945 Rules will require sustained funding and a significantly larger force of drug inspectors.
What This Means for You
For the consumer, these developments offer a new level of protection. When shopping for Ayush products, look for:
-
The Ayush Premium Mark: Indicates the product meets international quality standards.
-
Manufacturing License Numbers: Ensure the product is registered with state authorities.
-
Third-Party Certification: Evidence that the manufacturer has opted into voluntary quality schemes.
“Consumers should feel empowered, not intimidated,” says Dr. Verma. “The goal of these regulations is to ensure that when you reach for a traditional remedy, you are getting exactly what is on the label—nothing more, nothing less.”
References
-
Government Source: Ministry of Ayush, Press Information Bureau (PIB) Delhi. (2026, March 18). Strict Quality Standards Ensure Safety and Effectiveness of Ayush Medicines.
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
